PlainRecalls
FDA Drug Moderate Class II Terminated

Aloprim (allopurinol sodium) for Injection, 500 mg Single-Dose Vial, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103 USA. NDC: 67457-187-50

Reported: May 27, 2020 Initiated: May 5, 2020 #D-1271-2020

Product Description

Aloprim (allopurinol sodium) for Injection, 500 mg Single-Dose Vial, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103 USA. NDC: 67457-187-50

Reason for Recall

Discoloration: Out-of-specification results for appearance obtained during routine stability testing at the end of shelf-life for the parameters Appearance and Color of Solution.

Details

Recalling Firm
Mylan Institutional LLC
Units Affected
3,010 vials
Distribution
Distributed Nationwide in the USA
Location
Rockford, IL

Frequently Asked Questions

What product was recalled?
Aloprim (allopurinol sodium) for Injection, 500 mg Single-Dose Vial, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103 USA. NDC: 67457-187-50. Recalled by Mylan Institutional LLC. Units affected: 3,010 vials.
Why was this product recalled?
Discoloration: Out-of-specification results for appearance obtained during routine stability testing at the end of shelf-life for the parameters Appearance and Color of Solution.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 27, 2020. Severity: Moderate. Recall number: D-1271-2020.